Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study

Diabetes Care. 1982 Nov-Dec:5 Suppl 2:140-8. doi: 10.2337/diacare.5.2.s140.

Abstract

In two double-blind studies 66 insulin-dependent diabetic subjects pretreated with pork insulin were changed to human insulin (recombinant DNA) or a purified pork insulin preparation (regular and NPH insulin). Sixty-five patients previously pretreated with beef insulin were transferred, in a randomized, double-blind fashion, to human insulin and purified beef insulin of the same preparations (regular and NPH insulin). Patients' metabolic control, as demonstrated by fasting and 1-h postprandial blood glucose, HbA1c, and daily insulin dosage, over 4 mo was unchanged in our four groups compared with the values before changing insulin preparation. No severe hypoglycemic attacks or skin reactions were reported.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Animals
  • Blood Glucose
  • Cattle
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Double-Blind Method
  • Humans
  • Insulin / therapeutic use*
  • Insulin, Isophane / therapeutic use
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Swine

Substances

  • Blood Glucose
  • Insulin
  • Recombinant Proteins
  • Insulin, Isophane